Longevity Health and Spyglass Pharma Compared: Which Small-Cap Manufacturer Comes Out on Top?

A head-to-head review of the two small-cap biotech firms reveals key differences in profitability, valuation, and analyst recommendations.

Apr. 12, 2026 at 4:12pm

Got story updates? Submit your updates here. ›

A minimalist, photorealistic studio still life featuring a carefully arranged composition of premium, polished objects on a clean, monochromatic background, conceptually representing the abstract financial analysis of Longevity Health and Spyglass Pharma.An elegant studio still life captures the refined, analytical essence of the head-to-head review between these two small-cap biotech firms.Today in Pittsburgh

Longevity Health (NASDAQ:XAGE) and Spyglass Pharma (NASDAQ:SGP) are both small-cap manufacturing companies in the biotech industry. This article compares the two firms across several key metrics, including net margins, return on equity, revenue, earnings per share, and analyst recommendations, to determine which company is the superior investment.

Why it matters

Investors looking to gain exposure to the small-cap biotech space will want to carefully evaluate the relative strengths and weaknesses of Longevity Health and Spyglass Pharma to make an informed decision about which stock to add to their portfolio.

The details

The analysis finds that Spyglass Pharma has lower revenue but higher earnings than Longevity Health. Spyglass also scores better on 5 of the 8 factors compared, including net margins, return on equity, and analyst recommendations. However, Longevity Health has stronger institutional ownership, which can be a positive indicator of long-term performance.

  • The analysis is based on the latest financial data available as of April 12, 2026.

The players

Longevity Health

A small-cap manufacturing company in the biotech industry.

Spyglass Pharma

A small-cap manufacturing company in the biotech industry.

Got photos? Submit your photos here. ›

What’s next

Investors will want to closely monitor the ongoing financial performance and analyst coverage of both Longevity Health and Spyglass Pharma to see how the companies continue to stack up against each other.

The takeaway

This analysis highlights the importance of digging into the financial details and analyst perspectives when comparing small-cap biotech firms like Longevity Health and Spyglass Pharma. While both companies operate in the same industry, the data shows there are meaningful differences in their profitability, valuation, and market reception.